StockNews.com lowered shares of Amicus Therapeutics (NASDAQ:FOLD – Free Report) from a buy rating to a hold rating in a research report released on Monday morning. Several other research firms have also weighed in on FOLD. Needham & Company LLC reissued a “hold” rating on shares of Amicus Therapeutics in a research note on Thursday, […]

inTEST (NYSE:INTT – Get Free Report) was downgraded by stock analysts at Northland Capmk from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports. Northland Capmk also issued estimates for inTEST’s FY2029 earnings at $0.36 EPS. Other equities analysts have also issued research reports about the company. […]

StockNews.com cut shares of Cameco (NYSE:CCJ – Free Report) (TSE:CCO) from a hold rating to a sell rating in a research note issued to investors on Monday. Several other research analysts also recently commented on CCJ. Sanford C. Bernstein assumed coverage on shares of Cameco in a research note on Tuesday, April 1st. They issued […]

StockNews.com downgraded shares of Accuray (NASDAQ:ARAY – Free Report) from a buy rating to a hold rating in a research note issued to investors on Monday. Accuray Price Performance Accuray stock opened at $1.37 on Monday. The stock’s 50 day moving average price is $1.66 and its two-hundred day moving average price is $1.92. The […]

StockNews.com downgraded shares of Cimpress (NASDAQ:CMPR – Free Report) from a strong-buy rating to a buy rating in a research note published on Monday morning. A number of other research firms also recently commented on CMPR. Truist Financial dropped their price objective on Cimpress from $87.00 to $60.00 and set a “buy” rating for the […]

William Blair assumed coverage on shares of Roper Technologies (NYSE:ROP – Free Report) in a research note published on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating on the industrial products company’s stock. William Blair also issued estimates for Roper Technologies’ Q2 2025 earnings at $4.79 EPS, Q3 2025 earnings at $5.03 EPS, […]

StockNews.com upgraded shares of Iradimed (NASDAQ:IRMD – Free Report) from a buy rating to a strong-buy rating in a report issued on Tuesday. Separately, Roth Mkm reissued a “buy” rating and issued a $72.00 price objective (up from $60.00) on shares of Iradimed in a research report on Friday, February 14th. Check Out Our Latest […]

UBS Group upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC – Free Report) from a sell rating to a neutral rating in a report published on Monday morning, Marketbeat reports. They currently have $73.00 target price on the stock, down from their prior target price of $74.00. Several other brokerages have also recently issued reports on […]

StockNews.com started coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Needham & Company LLC reissued a “hold” rating on shares of Revance Therapeutics in a research report on Friday, January 17th. Nine analysts […]

HC Wainwright reaffirmed their buy rating on shares of Prelude Therapeutics (NASDAQ:PRLD – Free Report) in a report issued on Monday,Benzinga reports. HC Wainwright currently has a $5.00 price target on the stock. Separately, JMP Securities reaffirmed a “market outperform” rating and issued a $4.00 price target on shares of Prelude Therapeutics in a research […]